Drug intelligence / Profile preview

wogonin

Development stage
Unknown
Modality
Small Molecules
Administration
Topical
01

Overview

Wogonin is an O-methylated flavone and a flavonoid-like chemical compound primarily found in the root of the herb Scutellaria baicalensis. It exhibits multiple pharmacological activities including anti-inflammatory, antioxidant, anxiolytic without sedative or muscle-relaxing effects typical of benzodiazepines, anticonvulsant properties, and potential antitumor effects. Wogonin acts as a positive allosteric modulator at the benzodiazepine site of the GABAA receptor with moderate affinity (Ki ~0.92 μM), significantly less potent than diazepam but with lower toxicity (LD50 in mice ~3.9 g/kg). It also inhibits inflammatory mediators such as COX-2 and TNF-alpha by blocking phosphorylation pathways like p38 MAPK and JNK. Wogonin has shown chondroprotective effects by suppressing matrix-degrading enzymes (MMPs) relevant to osteoarthritis treatment and has been studied for topical application in joint diseases. It is under clinical trial investigation as an anti-cancer agent in China.[1][2][3][7][9]

Other names
5,7-dihydroxy-8-methoxyflavone5,7-dihydroxy-8-methoxy-2-phenyl-4H-chromen-4-one
02

Targets

JNK (Mitogen-activated protein kinase kinase kinase family)BZD site (GABA-A receptor benzodiazepine site)MAPK14 (p38 mitogen-activated protein kinase alpha)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on wogonin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on wogonin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call